SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and an advanced cancer that has spread or cannot be removed by surgery. It tests the safety and effectiveness of the immunotherapy drug nivolumab, given alone or…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New radiation technique may reduce lung and kidney damage in scleroderma stem cell transplants
Disease control Recruiting nowThis early-phase study tests whether a precise type of total body radiation (IMRT) combined with chemotherapy can safely prepare the body for a stem cell transplant in people with severe systemic sclerosis (scleroderma). The goal is to reduce radiation exposure to the lungs and k…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Family ties to scleroderma: a closer look
Knowledge-focused Recruiting nowThis study looks at people with systemic scleroderma who also have a family member with the disease. Researchers want to understand how the disease runs in families and find clues that could lead to better treatments. About 20 adults will take part, and no new treatments are bein…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
New light imaging could replace the pinch test for scleroderma patients
Knowledge-focused Recruiting nowThis study is testing a new, non-invasive imaging technique called spatial frequency domain imaging (SFDI) to measure skin thickness in people with scleroderma. Currently, doctors use a subjective pinch test, but SFDI uses light scattering to measure collagen in the skin more acc…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC